Sarkar Rashmi, Garg Vijay, Bansal Shivani, Sethi Sumit, Gupta Chitra
Department of Dermatology and Venereology, Maulana Azad Medical College and Associated Hospitals, New Delhi, India.
Dermatol Surg. 2016 Mar;42(3):384-91. doi: 10.1097/DSS.0000000000000642.
Melasma is acquired symmetric hypermelanosis characterized by light-to-deep brown pigmentation over cheeks, forehead, upper lip, and nose. Treatment of this condition is difficult and associated with high recurrence rates. Chemical peels have become a popular modality in the treatment of melasma.
To compare the therapeutic efficacy and tolerability of glycolic acid (35%) versus salicylic-mandelic (SM) acid (20% salicylic/10% mandelic acid) versus phytic combination peels in Indian patients with melasma.
Ninety patients diagnosed with melasma were randomly assigned into 3 groups of 30 patients each. Group A received glycolic acid (GA-35%) peel, Group B received SM acid, and Group C received phytic combination peels. Each group was primed with 4% hydroquinone and 0.05% tretinoin cream for 4 weeks before treatment. Chemical peeling was done after every 14 days in all groups until 12 weeks. Clinical evaluation using melasma area and severity index (MASI) score and photography was recorded at every visit and follow-up was done until 20 weeks.
There was a decrease in MASI score in all 3 groups but it was statistically significantly lower in Group A than Group C (p = .00), and it was also statistically significantly lower in Group B than Group C (p = .00) but there was no statistically significant difference between Groups A and B (p = .876). Objective response to treatment evaluated by reduction in MASI scoring after 12 weeks was 62.36% reduction in GA group, 60.98% reduction in SM group, and 44.71% in phytic acid group.
It is concluded that GA (35%) and SM acid peels are both equally efficacious and a safe treatment modality for melasma in Indian skin, and are more effective than phytic acid peels. Salicylic-mandelic peels are better tolerated and more suitable for Indian skin.
黄褐斑是一种获得性对称性色素沉着过度疾病,其特征为脸颊、前额、上唇和鼻子出现浅棕色至深棕色色素沉着。这种疾病的治疗困难且复发率高。化学剥脱术已成为治疗黄褐斑的一种常用方法。
比较乙醇酸(35%)、水杨酸 - 扁桃酸(SM酸,20%水杨酸/10%扁桃酸)和植酸联合剥脱术对印度黄褐斑患者的治疗效果和耐受性。
90例诊断为黄褐斑的患者被随机分为3组,每组30例。A组接受乙醇酸(GA - 35%)剥脱术,B组接受SM酸剥脱术,C组接受植酸联合剥脱术。每组在治疗前均先用4%氢醌和0.05%维甲酸乳膏治疗4周。所有组每14天进行一次化学剥脱,直至12周。每次就诊时使用黄褐斑面积和严重程度指数(MASI)评分进行临床评估,并拍照记录,随访至20周。
3组的MASI评分均有所下降,但A组在统计学上显著低于C组(p = 0.00),B组在统计学上也显著低于C组(p = 0.00),但A组和B组之间无统计学显著差异(p = 0.876)。12周后通过MASI评分降低评估的客观治疗反应为,GA组降低62.36%,SM组降低60.98%,植酸组降低44.71%。
得出的结论是,GA(35%)和SM酸剥脱术对印度皮肤的黄褐斑均同样有效且安全,并且比植酸剥脱术更有效。水杨酸 - 扁桃酸剥脱术耐受性更好,更适合印度皮肤。